Whether it’s explaining the terms and conditions of the latest DOT regulation, or debating the pros and cons of a new method of testing, we’re on top of our industry.
To view a report, select a report title from the list below.
WORKFORCE REPORTS:
- CANNABIDIOL (CBD)
- THE SAFETY LETTER
- FMCSA POST ACCIDENT TESTING CRITERIA
- MEDICATION AND SAFETY CONCERN
- RANDOM SELECTION PROBABILITIES
- RETURN TO DUTY DRUG TEST
- SAFETY PERFORMANCE HISTORY
- SPECIMEN VALIDITY TESTING
- HAIR TESTING – THE STATE OF THE SCIENCE 2018
- SHY BLADDER PROCEDURES
- URINE ALCOHOL TESTING
- FSS MEDICAL/RECREATIONAL MARIJUANIA
- DOT NPRM – JAN 2017 RE: ADDITION OF CERTAIN SCHEDULE II DRUGS TO DOT TESTING PANEL
- ODAPC PUBLISHED OFFICIAL Q&A AND REVISED COLLECTOR GUIDELINES
RECOVERY MANAGEMENT SOLUTIONS REPORTS:
- SPECIMEN SELECTION IN RECOVERY MONITORING
- BIOMARKERS
- CREATININE & SPECIFIC GRAVITIY
- DILUTE URINE SPECIMEN
- DILUTE URINE SPECIMENS – FOLLOW-UP
- DILUTION CONCERNS FOR RECOVERY MONITORING
- DRUG TESTING LABORATORY CERTIFICATION AND ACCREDITATION
- DRUGS ON THE STREET
- ETG ETS BIOMARKERS
- SPECIMEN VALIDITY TESTING
See All Resources